This knowledge gap leads to unrealistic expectations, poor compliance, and unnecessary anxiety when early results do not match what they imagined
Once it reaches the bloodstream, it is directly inactivated within seconds by the enzyme dipeptidyl peptidase-4 (DPP-4), which cleaves the peptide between positions 8 and 9, converting it into the truncated form GLP-1(936) amide
Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy
There are no tiered pricing structures, no surprise fees for higher doses, and no additional charges as treatment progresses
This is not pseudoscience